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This report describes a case of relapsing pneumococcal peri-
tonitis. The postulated source of infection was vaginal col-
onization and secondary adherence of pneumococci to an 
intrauterine contraceptive device. After immunization with 
a conjugate pneumococcal vaccine, her antibody levels were 
observed. She remained infection free at the 2-year follow-up 
investigation.
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Streptococcus pneumoniae is a commensal of the upper res-
piratory tract. Colonization is often symptomless, although it 
can progress to pneumonia or systemic invasive disease [1]. 
Uncommon colonization sites leading to invasive diseases may 
cause rare clinical manifestations. It then becomes a diagnostic 
challenge to find the source of infection. We report the case of a 
30-year-old woman with relapsing abdominal infection before 
detection of a colonized intrauterine contraceptive device. 
Vaginal colonization with S pneumoniae was proven on several 
visits. After removal of the device and antimicrobial treatment, 
the patient was vaccinated with the 13-valent pneumococcal 
polysaccharide conjugate vaccine. Her antibody response was 
observed for 2 years.
CASE REPORT
A 30-year-old mother of 2 sons (2 months and 2 years old) pre-
sented with a 4-day history of vomiting and diarrhea. She reported 
that her 2-year-old son had the same symptoms before she did. 
Thereafter, she became ill, followed by her husband, and finally 
her other son. All family members recovered except for her. She 
reported having abdominal cramps. On clinical examination she 
appeared dehydrated; blood pressure was 110/50 mmHg, heart 
rate was 110 beats per minute, and temperature was 39.9°C. Her 
abdomen was diffusely tender on palpation with slight rebound 
tenderness but no clear signs of acute abdomen. Laboratory exam-
ination of blood revealed white blood cell count of 7.6 × 109/L 
with a left shift and C-reactive protein level of 407 mg/L (normal, 
<5 mg/L). Abdominal ultrasound demonstrated free fluid in all 
quadrants and colon wall thickening surrounded by significant 
fluid. After blood cultures were obtained, the differential diag-
nosis of bacterial gastroenteritis was postulated, and rehydration 
and electrolyte substitution were prescribed.
Blood and stool cultures were negative. The latter was screened 
for Yersinia spp, Campylobacter spp, and Salmonella spp; exam-
inations for the presence of Clostridium difficile toxin and 
Norovirus were negative. Vaginal ultrasound showed no evidence 
of endometritis, adnexitis, or ovarian abscess. The intrauterine 
contraceptive device (IUCD) that was introduced 1 month pre-
viously was in the correct position and therefore left in situ. On 
day 3 of hospitalization, her clinical condition had not improved. 
In addition to a urine culture, blood cultures were obtained again 
and empiric antimicrobial treatment with ceftriaxone and metro-
nidazole was started. Streptococcus pneumoniae grew in all newly 
obtained blood and urine cultures. Treatment was switched to 
amoxicillin. Despite antimicrobial treatment, abdominal pain 
and fever persisted. Abdominal ultrasound was repeated and 
showed progressive cloudy ascites in multiple compartments. 
Thus, progressive pyogenic peritonitis was suspected, and surgi-
cal intervention indicated. Laparoscopy demonstrated general-
ized peritonitis with ascites and broad layers of fibrin in the whole 
abdomen (Figure 1). Fibrin was removed meticulously, and irri-
gation with 12 liters of Ringer solution was performed.
Intraoperative samples showed no bacterial growth, but S 
pneumoniae was detected via polymerase chain reaction (PCR). 
Thus, pneumococcal peritonitis was diagnosed. Antimicrobial 
treatment continued for a total of 14 days. The further course 
was favorable, and the patient discharged after 12 days of hos-
pitalization. A follow-up examination by her private gynecolo-
gist 1 month later was unremarkable. Streptococcus pneumoniae 
grew from a routinely obtained vaginal swab.
One week later (6 weeks after stopping antimicrobial treat-
ment), the patient was referred to our center again because of 
an acute abdomen. A computed tomography scan was consist-
ent with tubo-ovarian abscess on the right side and pyosalpinx 
on the left-side. Via laparoscopy, the abscess was incised and 
drained and the peritoneum irrigated. A  vaginal swab was 
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obtained and the IUCD removed. Streptococcus pneumoniae 
grew in all samples obtained during surgery as well as on the 
IUCD and on the vaginal swab. The diagnosis of recurrent 
pneumococcal peritonitis was made, and the colonized IUCD 
was considered as the source of infection. Empiric antimicro-
bial treatment with amoxicillin/clavulanate was streamlined 
to amoxicillin and continued for a total treatment duration of 
28  days. The following clinical course was favorable, and the 
patient was discharged after 5 days of hospitalization. 
Two weeks after cessation of antimicrobial treatment, the 
patient was vaccinated with 13-valent pneumococcal poly-
saccharide conjugate vaccine (PCV13). Clinical follow-up 
investigations 1  month and 2  years after vaccinations were 
unremarkable.
METHODS AND RESULTS
Susceptibility Tests
Minimum inhibitory concentrations of S pneumoniae strains 
isolated from both infection episodes were determined using 
Etests on Mueller-Hinton sheep blood agar plates; the ATCC 
49619 was used for quality control. The results were as follows: 
penicillin 0.016, vancomycin 0.50, doxycycline 0.125, clindamy-
cin 0.125, erythromycin 0.125, and moxifloxacin 0.19 μg/mL.
Polymerase Chain Reaction of Peritoneum Samples From the First 
Infection Episode
Multiplex PCR (Seeplex PneumoBacter ACE Detection, version 
3.0; Seegene Inc., Seoul, Korea), used according to the manu-
facturer’s instructions, detected S pneumoniae in peritoneum 
samples.
Capsular Serotyping and Multilocus Sequence Typing
Bacterial isolates from blood cultures (first infection episode), 
intraoperatively obtained samples (second infection episode), 
and the vaginal swab were characterized by capsular serotyp-
ing and multilocus sequence typing (MLST). Serotyping was 
performed by Quellung reaction with serotype-specific anti-
sera from the Statens Serum Institute (Copenhagen, Denmark), 
and MLST was performed as previously described [2, 3]. The 
Institute for Infectious Diseases, University of Bern, is the Swiss 
National Reference Centre for Pneumococci [4]. All isolates 
from both episodes were serotype 3 and MLST 1377.
Serum Antibody to Pneumococcal Capsular Polysaccharides
An enzyme-linked immunosorbent assay was used to assay 4 
serum samples for antibodies to 13 vaccine-type capsular pol-
ysaccharides (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 
23F). Serum was obtained during the second infection episode, 
56 days after initial presentation (serum 1, T-d56-inf2), after the 
second infection episode but before vaccination (serum 2, T-d98-
preVac), 1  month after vaccination (serum 3, T-d165-postVac), 
and 2 years after vaccination (serum 4, T-2y-FU). The assays were 
performed at the University College London Institute of Child 
Health (London, UK), a World Health Organization reference lab-
oratory for pneumococcal serology [5]. The patient responded to 
all the PCV13 serotypes except the infecting serotype 3 (Table 1). 
Antibody titers to serotype 23F were high before vaccination, 
indicating an earlier immune response, although no previous 
pneumococcal infection was reported in the patient history.
DISCUSSION
Peritonitis and pelvic inflammatory disease in adults are rare 
manifestations of pneumococcal disease. Pneumococcal peri-
tonitis is reported in 3 distinct patient groups [6, 7]. Namely, 
in patients with a pre-existing peritoneal disease (eg, cirrhosis, 
ascites), or when an infection of an intra-abdominal organ is 
present. The third group includes young, previously healthy 
women. In this group, pneumococcal peritonitis occurs post-
partum, after an abortion or gynecologic procedure, or in 
association with an IUCD [6–8]. A frequently postulated patho-
genesis is an ascendant infection from a genitourinary source 
Figure 1. Intraoperative image: laparoscopy demonstrated generalized peritoni-
tis with ascites and broad layers of fibrin in the whole abdomen.
Table 1. Antibody Levels Against Pneumococcal Serotypesa
Serum
Samples T-d56-inf2 T-d98-preVac T-d165-postVac T-2y-FU
Serotype
1 <0.150 <0.150 3.532 1.600
3 0.192 0.210 0.201 0.334
4 <0.150 <0.150 1.462 0.259
5 <0.150 <0.150 2.841 0.649
6A 0.204 0.314 20.100 6.840
6B 0.152 0.252 8.523 3.753
7F 0.252 0.210 1.751 0.466
9V 0.193 0.282 10.164 3.570
14 0.783 0.826 6.825 3.057
18C 2.163 6.879 27.159 12.604
19A 0.190 0.270 6.342 1.713
19F 0.236 0.399 11.343 4.110
23F 22.668 25.614 13.617 7.861
aSerum samples: T-d56-inf2 (during second infection episode, day 56 after first clinical pre-
sentation), T-d98-preVac (after second infection episode, immediately before vaccination 
with the 13-valent pneumococcal conjugate vaccine), T-d165-postVac 1 month after vacci-
nation, T-2y-FU (2 years after vaccination).
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[8–10], and the disease manifests as complicated salpingitis or 
pyosalpinx [6, 7]. After peritoneal infection, bacteremia may 
occur. This sequence in the pathogenesis of pneumococcal 
peritonitis is believed to arise more frequently than is hematog-
enous spread to an uninfected peritoneum [9].
In this study, pneumococcal vaginal colonization was proven in 
an asymptomatic episode after the first infection episode and dur-
ing the second infection episode. It is conceivable that the IUCD 
was secondarily colonized after its introduction and served as the 
source for both infection episodes. Although S pneumoniae typ-
ically colonizes the upper respiratory tract, it can be part of the 
commensal flora of the female genital tract [11]. The proportion 
of women vaginally colonized with S pneumoniae is unknown, 
because antenatal screening and corresponding epidemiologi-
cal results report on group B Streptococcus. In 1987, Darbás and 
Boyer [12] found 7 pneumococcal isolates in 1064 (0.75%) vagi-
nal secretions. It is unclear how long vaginal colonization with S 
pneumoniae persists. Study results on nasal colonization cannot be 
uncritically extrapolated to other body sites [13, 14]. The effect of 
pneumococcal vaccination on vaginal colonization is unknown.
CONCLUSIONS
In conclusion, vaginal S pneumoniae colonization is uncom-
mon but may be the source of invasive disease. This case and 
other reports from the literature [6–9] suggest that pneumo-
coccal peritonitis in previously healthy young women should 
raise the suspicion of an ascending infection from the genito-
urinary tract. If present, the IUCD must be removed [9, 10]. 
Immunization with PCV13 is effective except against serotypes 
that previously caused an infection [15]. The long-term clinical 
benefit of vaccinating young adults who have experienced inva-
sive pneumococcal disease is unknown.
Acknowledgments
We thank the patient for supporting publication of this article. We ac-
knowledge the many physicians, surgeons, and nurses involved in patient 
care, including Daniela Lengsfeld, Corina Kim Fuchs, Christoph Hauser, 
Marc Baumann, and Luigi Raio, among others. We thank Marianne Küffer, 
Suzanne Aebi, Sarah Schaller, and Polly Burbidge for performing serotyp-
ing, multilocus sequence typing and enzyme-linked immunosorbent assay. 
Barbara Every, ELS, of BioMedical Editor, St. Albert, Alberta, Canada, pro-
vided English language editing.
Potential conflicts of interest. All authors: No reported conflicts. 
All authors have submitted the ICMJE Form for Potential Conflicts of 
Interest. Conflicts that the editors consider relevant to the content of the 
manuscript have been disclosed.
References
1. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the 
key to pneumococcal disease. Lancet Infect Dis 2004; 4:144–54.
2. Hathaway LJ, Stutzmann Meier P, Bättig P, et al. A homologue of aliB is found 
in the capsule region of nonencapsulated Streptococcus pneumoniae. J Bacteriol 
2004; 186:3721–9.
3. Jolley KA, Maiden MC. BIGSdb: scalable analysis of bacterial genome variation at 
the population level. BMC Bioinformatics 2010; 11:595.
4. Kronenberg A, Zucs P, Droz S, Muhlemann K. Distribution and invasiveness of 
Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic 
selection pressure, from 2001 to 2004. J Clin Microbiol 2006; 44:2032–8.
5. Andrews NJ, Waight PA, Burbidge P, et al. Serotype-specific effectiveness and cor-
relates of protection for the 13-valent pneumococcal conjugate vaccine: a postli-
censure indirect cohort study. Lancet Infect Dis 2014; 14:839–46.
6. Capdevila O, Pallares R, Grau I, et al. Pneumococcal peritonitis in adult patients: 
report of 64 cases with special reference to emergence of antibiotic resistance. 
Arch Intern Med 2001; 161:1742–8.
7. Dugi DD 3rd, Musher DM, Clarridge JE 3rd, Kimbrough R. Intraabdominal 
infection due to Streptococcus pneumoniae. Medicine (Baltimore) 2001; 
80:236–44.
8. Westh H, Skibsted L, Korner B. Streptococcus pneumoniae infections of the female 
genital tract and in the newborn child. Rev Infect Dis 1990; 12:416–22.
9. Hemsley C, Eykyn SJ. Pneumococcal peritonitis in previously healthy adults: case 
report and review. Clin Infect Dis 1998; 27:376–9.
10. Lemoyne S, Van Leemput J, Smet D, et  al. Pelvic inflammatory disease due to 
Streptococcus pneumoniae: a usual pathogen at an unusual place. Acta Clin Belg 
2008; 63:398–401.
11. Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract. 
Clin Infect Dis 2001; 32:e69–77.
12. Darbás H, Boyer G. [Isolation of Streptococcus pneumoniae from genital samples. 
Discussion of its pathogenic role]. Pathol Biol 1987; 35:177–80.
13. Weinberger DM, Dagan R, Givon-Lavi N, et al. Epidemiologic evidence for sero-
type-specific acquired immunity to pneumococcal carriage. J Infect Dis 2008; 
197:1511–8.
14. Sjöström K, Spindler C, Ortqvist A, et  al. Clonal and capsular types decide 
whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect 
Dis 2006; 42:451–9.
15. Borrow R, Stanford E, Waight P, et al. Serotype-specific immune unresponsive-
ness to pneumococcal conjugate vaccine following invasive pneumococcal dis-
ease. Infect Immun 2008; 76:5305–9.
